Berry Genomics: Shareholder Gao Yang's 1% stake in the company will be subject to judicial enforcement

Berry Genomics announced that its shareholder Gao Yang, who holds more than 5% of the shares, has defaulted on a stock pledge repurchase business. The Chengyu Financial Court has ruled to forcibly liquidate his 3,535,214 shares of "Berry Genomics," accounting for 1% of the company's total share capital. This matter will not have a significant adverse impact on the company's production, operation, and financial condition, nor will it have a significant adverse impact on the company's governance structure